hemgenix
csl behring gmbh - etranacogene dezaparvovec - hæmofili b - other hematological agents - treatment of severe and moderately severe haemophilia b (congenital factor ix deficiency) in adult patients without a history of factor ix inhibitors.
degarelix accord
accord healthcare s.l.u. - degarelix acetate - prostatiske neoplasmer - other hormone antagonists and related agents - degarelix accord is a gonadotrophin releasing hormone (gnrh) antagonist indicated:for treatment of adult male patients with advanced hormone-dependent prostate cancer. for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.
orfiril long 150 mg depotkapsler, hårde
paranova danmark a/s - natriumvalproat - depotkapsler, hårde - 150 mg
androgel 50 mg/dosis gel, brev
2care4 aps - testosteron - gel, brev - 50 mg/dosis
testogel 50 mg/dosis transdermal gel
laboratoires besins int. s.a.s. - testosteron - transdermal gel - 50 mg/dosis
testogel 50 mg/dosis transdermal gel
orifarm a/s - testosteron - transdermal gel - 50 mg/dosis
androgel 16,2 mg/g gel
besins healthcare - testosteronenantat - gel - 16,2 mg/g
valproat "life medical" 100 mg/ml injektions-/infusionsvæske, opløsning
life medical aps - natriumvalproat - injektions-/infusionsvæske, opløsning - 100 mg/ml
delepsine 300 mg suppositorier
orion corporation - natriumvalproat - suppositorier - 300 mg
depakine chrono 500 mg depottabletter
orifarm a/s - natriumvalproat, valproinsyre - depottabletter - 500 mg